Sulfadoxine-Pyrimethamine in Treatment of Malaria in Western Kenya: Increasing Resistance and Underdosing

Between 1993 and 1999, we monitored the efficacy of sulfadoxine-pyrimethamine in 1,175 children aged <24 months receiving 2,789 treatments for falciparum malaria in western Kenya using a widely deployed age-based dose regimen: infants, 125 plus 6.25 mg (sulfadoxine plus pyrimethamine); children a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Terlouw, Dianne J., Nahlen, Bernard L., Courval, Jeanne M., Kariuki, Simon K., Rosenberg, Oren S., Oloo, Aggrey J., Kolczak, Margarette S., Hawley, William A., Lal, Altaf A., Kuile, Feiko O. ter
Format: Article
Langue:en
Publié: American Society for Microbiology 2003
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC182608/
https://ncbi.nlm.nih.gov/pubmed/12936996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.9.2929-2932.2003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC182608/
https://ncbi.nlm.nih.gov/pubmed/12936996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.9.2929-2932.2003

Documents similaires